Clinical Trials Browser

Phase 2 × Fallopian Tube Neoplasms × cemiplimab × Clear all

NCT06787612 2026-04-08

Investigation of Ubamatamab Combination Therapy in Adult Participants With Platinum-Resistant Ovarian Cancer

Phase 2 Recruiting

Fallopian Tube Neoplasms, Ovarian Neoplasms